Linked Life Data

20457794

Source:http://linkedlifedata.com/resource/pubmed/id/20457794

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2010-5-11
pubmed:abstractText
Cardiovascular molecular imaging is a new discipline that integrates scientific advances in both functional imaging and molecular probes to improve our understanding of the molecular basis of the cardiovascular system. These advances are driven by in vivo imaging of molecular processes in animals, usually small animals, and are rapidly moving toward clinical applications. Molecular imaging has the potential to revolutionize the diagnosis and treatment of cardiovascular disease. The 2 key components of all molecular imaging systems are the molecular contrast agents and the imaging system providing spatial and temporal localization of these agents within the body. They must deliver images with the appropriate sensitivity and specificity to drive clinical applications. As work in molecular contrast agents matures and highly sensitive and specific probes are developed, these systems will provide the imaging technologies required for translation into clinical tools. This is the promise of molecular medicine.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1535-5667
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
51 Suppl 1
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
38S-50S
pubmed:dateRevised
2010-12-30
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Multimodality cardiovascular molecular imaging technology.
pubmed:affiliation
University of Washington, Seattle, Washington, USA.
pubmed:publicationType
Journal Article, Review, Research Support, N.I.H., Intramural